Although we observed intra-tumor heterogeneity, Bcl2l1 expression in tumor lesions was higher than in non-tumor lesions in all states (Fig. 4A), whereas Mcl1 expression was less tumor-specific and relatively lower in recurrent lesions. The gene discussed is BCL2L1; the disease is neoplasm.